Spell out 'acetaminophen' for patients' sake, group says
- Products return to marketplace. // Chain Drug Review;9/27/2010, Vol. 32 Issue 16, p30
The article announces the return of acetaminophen suppositories into the market after the U.S. Food and Drug Administration ordered pharmaceutical companies to add a new warning on the labels of drugs containing acetaminophen.
- ALIMERA ENTERS INTO LABELING DISCUSSIONS WITH FDA. // Medical Device Daily;12/20/2013, Vol. 17 Issue 245, p8
The article reports that biopharmaceutical company Alimera Sciences has met with U.S. Food and Drug Administration (FDA) officials to discuss applicable labeling for Iluvien, its sustained release intravitreal implant, and to know the next steps needed to move the product closer to an FDA approval.
- Sunscreen labeling changes - what to tell your patients. // Dermatology Times;Jun2012, Vol. 33 Issue 6, p24
The article focuses on the delay of new U.S. Food and Drug Administration's (FDA) regulations related to sunscreen packaging. The regulations will require specific testing for ultraviolet A (UVA) protection of sunscreen products by manufacturers. For broad-spectrum labelling of products, the...
- News Brief. // American Journal of Health-System Pharmacy;5/1/2013, Vol. 70 Issue 9, p750
The article reports that the Food and Drug Administration (FDA) has issued new criteria that new solid oral dosage forms must meet for their labeling to describe them as having functional scoring.
- Risky-drugs list in the spotlight. Rhea, Shawn // Modern Healthcare;8/9/2010, Vol. 40 Issue 32, p14
The article reports that healthcare professionals, patient groups and drug manufacturers are concerned about the list of drug-safety requirements issued under the U.S. Food and Drug Administration's Risk Evaluation and Mitigation Strategies (REMS). They agree that the program is needed to allow...
- FDA finalizes rules on faster approval for some drugs. Dickson, Virgil // Modern Healthcare;6/2/2014, Vol. 44 Issue 22, p13
The article reports on the U.S. Food & Drug Administration's (FDA) finalized guidance for faster approval of drugs. It mentions that guidance describes four expedited programs and the criteria which qualify drug for pathways of faster approval, a draft version of the guidance received components...
- FDA seeks to standardize medication information. Dickson, Virgil // Modern Healthcare;6/30/2014, Vol. 44 Issue 26, p4
The article reports that the U.S. Food and Drug Administration is engaged in developing regulations that would require a single document for prescription drugs, known as patient medication information (PMI), and discusses a public meeting to be organized by the Brookings Institution in July 2014.
- Tylenol maker to warn parents about overdose risks. // Child Health Alert;Nov97, Vol. 15, p1
Reports that McNeil Consumer Products, the manufacturer of Tylenol or acetaminophen drug will inform parents about the correct dosages of the drug for children. Recommendation of the US Food and Drug Adminstration on additional changes and development of the drug's label; Comment on the news...
- Vitamin D supplement labels may be misleading. // Dermatology Times;Mar2013, Vol. 34 Issue 3, p10
The article reports that vitamin D supplement labels may mislead over-the-counter (OTC) and states that Food and Drug Administration (FDA) does not regulate vitamin D supplements which leads to less evaluated strength.